Pharmaceutical Headlines for June 2, 2011 ( Thursday ).
• Silence Therapeutics plc to Close US Operations in Reorganization, Search on for New CEO More...
• AlphaRx International Holdings Limited Terminates Its Chief Scientist and Chief Medical Officer for Cause More...
• Marshall Edwards, Inc. (MSHL) Adds Former Genentech (RHHBY) Head of Medical Affairs Robert Mass as Chief Medical Officer More...
• Apricus Biosciences (APRI) Appoints Steve Martin as Senior Vice President and Chief Financial Officer More...
• Soligenix Appoints Joseph Warusz as Vice President of Administration and Controller More...
• British Firm Sagentia to Add Jobs in Massachusetts More...
• Novo Nordisk A/S (NVO) Will Boost China Investments to Fend Off Sanofi (France) (SASY.PA), COO Says More...
• Sequenom Inc. (SQNM) Enters Into New $30.0 Million Credit Facility More...
• Healthpoint Acquires Regranex® Gel More...
• Global Pharm Holdings Group Completes Acquisitions for Two City-Level Pharmaceutical Distribution Companies More...
• INC Research, Inc. Expands Reach in Australia, New Zealand and India WithTrident Clinical Research Acquisition More...
• Ortho-McNeil Pharmaceutical, Inc. Ditches $625 Million Diabetes Drug Pact with Diamyd Medical AB More...
• Bristol-Myers Squibb Canada (BMY) and Roche (RHHBY) Enter into a Clinical Collaboration Agreement to Conduct Combination Studies with YERVOY(TM) (ipilimumab) and Vemurafenib More...
• Teva Pharmaceutical Industries Limited (TEVA) Eyes Deals in India, Gets US OK for Generic Aricept More...
• Luminex Corporation (LMNX) and Life Technologies (LIFE) Sign Agreement for Global Distribution of the Award-Winning MAGPIXĂ‚® Multiplexing Instrument More...
• Goodwin Biotechnology, Inc. Announces a Collaboration With Alethia BioTherapeutics, Inc. More...
• PAREXEL International (PRXL) Issues Earnings Guidance in Conjunction with Investor Day More...
• South Carolina Prosecutor Suing GlaxoSmithKline (GSK) Over Avandia More...
• GlaxoSmithKline (GSK) and Theravance, Inc. (THRX) Announce Results of Two Pivotal Phase III Studies for Relovair(TM) in COPD; Results Support Continuation of Development Program More...
• Adeona Pharmaceuticals (AEN) Announces Positive Alzheimer's Subgroup Analysis that Supports Additional Clinical Study of Proprietary Zinc-Based Therapy More...
• Lpath, Inc.'s Anti-LPA Antibody, Lpathomab, Demonstrates Promising Data in Several Animal Models of Disease More...
• Seaside Therapeutics Initiates Pivotal Phase 3 Study of STX209 in Fragile X Syndrome More...
• Mylan Laboratories Inc. (MYL) Receives Approval for Generic Version of Effexor XR(R) Capsules More...
• NovaDel Pharma (NVD) Reports Opening of Duromist(TM) Original IND with FDA More...
• Vaccine May Help Treat Advanced Melanoma: M. D. Anderson Cancer Center More...
• Cholesterol Drugs Tied to Lower Prostate Cancer Risk, Duke University School of Medicine Study More...
• FDA: Treatment With Angiotensin Receptor Blockers for High Blood Pressure Does Not Increase Risk of Cancer More...
• Childhood ADHD Linked to Later Risk of Drug Abuse: Journal of the American Academy of Child & Adolescent Psychiatry More...
• Silence Therapeutics plc to Close US Operations in Reorganization, Search on for New CEO More...
• AlphaRx International Holdings Limited Terminates Its Chief Scientist and Chief Medical Officer for Cause More...
• Marshall Edwards, Inc. (MSHL) Adds Former Genentech (RHHBY) Head of Medical Affairs Robert Mass as Chief Medical Officer More...
• Apricus Biosciences (APRI) Appoints Steve Martin as Senior Vice President and Chief Financial Officer More...
• Soligenix Appoints Joseph Warusz as Vice President of Administration and Controller More...
• British Firm Sagentia to Add Jobs in Massachusetts More...
• Novo Nordisk A/S (NVO) Will Boost China Investments to Fend Off Sanofi (France) (SASY.PA), COO Says More...
• Sequenom Inc. (SQNM) Enters Into New $30.0 Million Credit Facility More...
• Healthpoint Acquires Regranex® Gel More...
• Global Pharm Holdings Group Completes Acquisitions for Two City-Level Pharmaceutical Distribution Companies More...
• INC Research, Inc. Expands Reach in Australia, New Zealand and India WithTrident Clinical Research Acquisition More...
• Ortho-McNeil Pharmaceutical, Inc. Ditches $625 Million Diabetes Drug Pact with Diamyd Medical AB More...
• Bristol-Myers Squibb Canada (BMY) and Roche (RHHBY) Enter into a Clinical Collaboration Agreement to Conduct Combination Studies with YERVOY(TM) (ipilimumab) and Vemurafenib More...
• Teva Pharmaceutical Industries Limited (TEVA) Eyes Deals in India, Gets US OK for Generic Aricept More...
• Luminex Corporation (LMNX) and Life Technologies (LIFE) Sign Agreement for Global Distribution of the Award-Winning MAGPIXĂ‚® Multiplexing Instrument More...
• Goodwin Biotechnology, Inc. Announces a Collaboration With Alethia BioTherapeutics, Inc. More...
• PAREXEL International (PRXL) Issues Earnings Guidance in Conjunction with Investor Day More...
• South Carolina Prosecutor Suing GlaxoSmithKline (GSK) Over Avandia More...
• GlaxoSmithKline (GSK) and Theravance, Inc. (THRX) Announce Results of Two Pivotal Phase III Studies for Relovair(TM) in COPD; Results Support Continuation of Development Program More...
• Adeona Pharmaceuticals (AEN) Announces Positive Alzheimer's Subgroup Analysis that Supports Additional Clinical Study of Proprietary Zinc-Based Therapy More...
• Lpath, Inc.'s Anti-LPA Antibody, Lpathomab, Demonstrates Promising Data in Several Animal Models of Disease More...
• Seaside Therapeutics Initiates Pivotal Phase 3 Study of STX209 in Fragile X Syndrome More...
• Mylan Laboratories Inc. (MYL) Receives Approval for Generic Version of Effexor XR(R) Capsules More...
• NovaDel Pharma (NVD) Reports Opening of Duromist(TM) Original IND with FDA More...
• Vaccine May Help Treat Advanced Melanoma: M. D. Anderson Cancer Center More...
• Cholesterol Drugs Tied to Lower Prostate Cancer Risk, Duke University School of Medicine Study More...
• FDA: Treatment With Angiotensin Receptor Blockers for High Blood Pressure Does Not Increase Risk of Cancer More...
• Childhood ADHD Linked to Later Risk of Drug Abuse: Journal of the American Academy of Child & Adolescent Psychiatry More...
0 comments